Erin L. Winstanley, PhD

  • CHAMPP Core Faculty
  • Professor of Medicine
Dr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health, her postdoctoral training was in behavioral pharmacology, and she has 25+ years of experience as a behavioral health services researcher. She is the Multiple Principal Investigator (mPI) of the Appalachian Node of the NIDA Clinical Trials Network (CTN), and she is a member of the Tailored Retention and Engagement for Equitable Treatment of Opioid Use Disorder and Pain (TREETOP) study team. Her current research is focused on reducing the morbidity and mortality associated with the overdose epidemic, as well as the use of technology to improve access and quality of behavioral health services. She has expertise in rural health, clinical trials, patient-reported outcomes, and health policy. Her work is committed to discovering and implementing evidence-based strategies to improve health outcomes for individuals with behavioral health problems. She has extensive experience working with trainees, clinicians, community organizations and key stakeholders.

Dr. Winstanley is an active member and former Board Member of the College on the Problems of Drug Dependence (CPDD), the longest standing professional association in the United States that focuses on substance use, misuse, and substance use disorders. Prior to becoming interested in research as an undergraduate, she was pursuing theatrical training at the Educational Center for the Arts (ECA) and the Carnegie Mellon University Pre-College Drama program. In her personal time, she enjoys biking, hiking and camping.

Education & Training

  • BA, Sociology, Southern Connecticut State University, 1993
  • MA, Sociology, University of Illinois at Chicago, 1996
  • PhD, Health Policy & Management (Health Services Research Track), Johns Hopkins University, Bloomberg School of Public Health, 2006 Representative Publications

Representative Publications